Apis Capital Advisors, LLC Amarin Corp Plcuk Transaction History

Apis Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $1.15 Million - $1.76 Million	-270,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $1.36 Million - $2.38 Million	270,000 New	270,000 $1.68 Million
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $1.65 Million - $2.17 Million	-409,600 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $5.17 Million - $8.62 Million	-372,400 Reduced 47.62%	409,600 $6.21 Million
Q2 2019 Aug 13, 2019	SELL	$16.27 - $20.51 $5.61 Million - $7.07 Million	-344,700 Reduced 30.59%	782,000 $15.2 Million
Q1 2019 May 07, 2019	SELL	$12.61 - $22.33 $445,133 - $788,248	-35,300 Reduced 3.04%	1,126,700 $23.4 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $14.4 Million - $26.7 Million	1,162,000 New	1,162,000 $15.8 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $194M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.